J and J Snack Foods News

J & J Snack Foods Corp. announced today that its Board of Directors has declared a regular quarterly cash dividend of $.13 per share of its common stock payable on April 4, 2012 to shareholders of record as of the close of business on March 15, 2012.

MadeByMark.com is an online journal written by Mark McElroy, an author, writer, media creator, and communications guy in Midtown Atlanta.

IEEE, the world's largest technical professional association, announced the addition of Rodney Spady as senior director, digital marketing and communications.

Johnson & Johnson may invest $85 million or more in Salt Lake City-based Coherex Medical Inc., a medical device maker, and possibly purchase the company in about six months.

The Food and Drug Administration on Thursday created the first shortcut to the U.S. market for "biosimilar" drugs - cheaper versions of expensive and complex medicines made from biological matter.

Recipients of Johnson & Johnson hip implants recalled by the company were improperly solicited as clients by an Atlanta law firm using confidential patient data, according to lawyers defending a suit against a J&J distributor.

NEW YORK &#8212 Watson Pharmaceuticals Inc. said Wednesday it settled a patent lawsuit brought by a unit of Johnson & Johnson over a generic version of the birth control drug Ortho Tri-Cyclen Lo.

These stocks are currently rated as a Zacks Rank #5 : J&J Snack Foods Corp. and Ralcorp Holdings, Inc.

After several years of topsy-turvy markets, some investors would do just about anything to get a smoother ride for their portfolios .

Johnson & Johnson, the world's second-biggest health-care company, forecast 2012 earnings that missed analyst estimates and said fourth-quarter profit plunged 89 percent on legal settlements and an artificial hip recall.

After a week of speculation AstraZeneca officially announced plans to eliminate thousands of jobs as part of a restructuring designed to save the company $1.6 billion annually by 2014.

It covers the period from October 15 to November 14, 2011. Scope * Enhance your understanding of trends in the food industry by accessing the latest news and insight.

JOHNSON & Johnson Medical Ltd and its Shanghai branch company faced accusations of price fixing in a local court yesterday after one of its distributors claimed the company had set a minimum resale price for its suturing products, which violated China's Anti-Monopoly Law.

Merck & Co on Thursday reported better-than-expected fourth-quarter earnings , helped by a decrease in research spending, and predicted relatively flat 2012 results as the No.

Two people who received a metal hip replacement are suing the manufacturers of the artificial joints after they allegedly failed repeatedly.

SIX years ago, when Chris Hacker became chief design officer at Johnson & Johnson and began plotting to modernize the look of Band-Aids and baby shampoo, a friend sent him a hot water bottle with a symbol of a cross on its red-and-white knitted cover.

More quality control issues at Johnson & Johnson have spurred yet another consumer product recall.

A Johnson & Johnson prostate-cancer medicine discovered in England and developed with funds from U.K. charities is too expensive for the country's National Health Service.

Feb 01st 2012 - Edison Investment Research today published a report on Quickview entitled "Unlocking Abstral's Value". In summary, the report says: Orexo's shares slipped 11% on news that a preclinical stage collaboration with J&J in arachidonic acid research has been terminated.

Johnson & Johnson has recalled Aveeno baby calming comfort lotion, lot number 0161LK, in Alabama, Arkansas, Florida, Georgia, Kansas, Louisiana, Mississippi, Tennessee and Texas.